Correlation Between VistaGen Therapeutics and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and Carmell Therapeutics, you can compare the effects of market volatilities on VistaGen Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and Carmell Therapeutics.
Diversification Opportunities for VistaGen Therapeutics and Carmell Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between VistaGen and Carmell is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and Carmell Therapeutics
Given the investment horizon of 90 days VistaGen Therapeutics is expected to generate 0.36 times more return on investment than Carmell Therapeutics. However, VistaGen Therapeutics is 2.8 times less risky than Carmell Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 309.00 in VistaGen Therapeutics on August 31, 2024 and sell it today you would lose (40.00) from holding VistaGen Therapeutics or give up 12.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
VistaGen Therapeutics vs. Carmell Therapeutics
Performance |
| Timeline |
| VistaGen Therapeutics |
| Carmell Therapeutics |
VistaGen Therapeutics and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VistaGen Therapeutics and Carmell Therapeutics
The main advantage of trading using opposite VistaGen Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| VistaGen Therapeutics vs. Cue Biopharma | VistaGen Therapeutics vs. Eliem Therapeutics | VistaGen Therapeutics vs. Inhibrx | VistaGen Therapeutics vs. Molecular Partners AG |
| Carmell Therapeutics vs. ZyVersa Therapeutics | Carmell Therapeutics vs. Sonnet Biotherapeutics Holdings | Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |